TCRT
Price:
$2.26
Market Cap:
$5.52M
Alaunos Therapeutics, Inc. is an oncology company in the clinical trial phase, specializing in the creation of adoptive T-cell receptor (TCR) engineered therapies. Their pipeline includes a TCR Library, currently undergoing Phase I/II clinical trials, which comprises ten T-cell receptors designed to target mutated KRAS, TP53, and EGFR in various cancers such as non-small cell lung, colorectal, endometrial, pancreatic, ovarian, and bile duct cancers. Additionally, they are advancing hunTR, a platform focused on human neoantigen T-cell receptors, and mbIL-15, intended for solid tumor treatment. The company maintains strategic collaborations, including a licensing agreement with PGEN Therapeuti...[Read more]
Industry
Biotechnology
IPO Date
2005-08-24
Stock Exchange
NASDAQ
Ticker
TCRT
According to Alaunos Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 5.17M. This represents a change of 10.48% compared to the average of 4.68M of the last 4 quarters.
The mean historical Enterprise Value of Alaunos Therapeutics, Inc. over the last ten years is 278.00M. The current 5.17M Enterprise Value has changed 85.80% with respect to the historical average. Over the past ten years (40 quarters), TCRT's Enterprise Value was at its highest in in the June 2019 quarter at 843.82M. The Enterprise Value was at its lowest in in the December 2024 quarter at 1.97M.
Average
278.00M
Median
197.18M
Minimum
1.97M
Maximum
715.34M
Discovering the peaks and valleys of Alaunos Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 246.19%
Maximum Annual Enterprise Value = 715.34M
Minimum Annual Increase = -91.06%
Minimum Annual Enterprise Value = 1.97M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 4.91M | 149.48% |
| 2024 | 1.97M | -81.97% |
| 2023 | 10.91M | -91.06% |
| 2022 | 121.96M | -35.04% |
| 2021 | 187.73M | -55.09% |
| 2020 | 418.03M | -41.56% |
| 2019 | 715.34M | 246.19% |
| 2018 | 206.63M | -58.34% |
| 2017 | 495.98M | -19.55% |
| 2016 | 616.54M | -31.61% |
The current Enterprise Value of Alaunos Therapeutics, Inc. (TCRT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
5.93M
5-year avg
65.50M
10-year avg
278.00M
Alaunos Therapeutics, Inc.’s Enterprise Value is less than Radiopharm Theranostics Limited (12.78M), less than Cyclerion Therapeutics, Inc. (11.25M), greater than Pasithea Therapeutics Corp. (-46001320.00), greater than VYNE Therapeutics Inc. (-13823812.00), less than Quoin Pharmaceuticals, Ltd. (5.31M), greater than Addex Therapeutics Ltd (4.62M), less than Polyrizon Ltd. (11.16M), greater than AIM ImmunoTech Inc. (139.50K), less than XTL Biopharmaceuticals Ltd. (5.58M), less than Impact BioMedical Inc. (7.29M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 12.78M | $5.50M | |
| 11.25M | $14.07M | |
| -46001320.00 | $4.40M | |
| -13823812.00 | $10.81M | |
| 5.31M | $8.43M | |
| 4.62M | $4.65M | |
| 11.16M | $12.47M | |
| 139.50K | $1.38M | |
| 5.58M | $5.04M | |
| 7.29M | $7.31M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Alaunos Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Alaunos Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Alaunos Therapeutics, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Alaunos Therapeutics, Inc. (TCRT)?
What is the 3-year average Enterprise Value for Alaunos Therapeutics, Inc. (TCRT)?
What is the 5-year average Enterprise Value for Alaunos Therapeutics, Inc. (TCRT)?
How does the current Enterprise Value for Alaunos Therapeutics, Inc. (TCRT) compare to its historical average?